PT879228E - Processo para a preparacao de d-treo-(r,r)-metilfenidato e reciclagem de enantiomeros indesejaveis por epimerizacao - Google Patents
Processo para a preparacao de d-treo-(r,r)-metilfenidato e reciclagem de enantiomeros indesejaveis por epimerizacaoInfo
- Publication number
- PT879228E PT879228E PT97902435T PT97902435T PT879228E PT 879228 E PT879228 E PT 879228E PT 97902435 T PT97902435 T PT 97902435T PT 97902435 T PT97902435 T PT 97902435T PT 879228 E PT879228 E PT 879228E
- Authority
- PT
- Portugal
- Prior art keywords
- methylphenidate
- treo
- epimerization
- unsafe
- recycling
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000006345 epimerization reaction Methods 0.000 title 1
- 229960001344 methylphenidate Drugs 0.000 title 1
- 238000004064 recycling Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 abstract 1
- DUGOZIWVEXMGBE-OLZOCXBDSA-N methyl (S)-phenyl[(R)-piperidin-2-yl]acetate Chemical compound C([C@@H]1[C@@H](C(=O)OC)C=2C=CC=CC=2)CCCN1 DUGOZIWVEXMGBE-OLZOCXBDSA-N 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/0004—Crystallisation cooling by heat exchange
- B01D9/0013—Crystallisation cooling by heat exchange by indirect heat exchange
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9602174.6A GB9602174D0 (en) | 1996-02-02 | 1996-02-02 | Resolution/racemization process |
| GBGB9618836.2A GB9618836D0 (en) | 1996-09-10 | 1996-09-10 | Resolution/racemisation process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT879228E true PT879228E (pt) | 2003-01-31 |
Family
ID=26308593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97902435T PT879228E (pt) | 1996-02-02 | 1997-01-31 | Processo para a preparacao de d-treo-(r,r)-metilfenidato e reciclagem de enantiomeros indesejaveis por epimerizacao |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7164025B2 (pt) |
| EP (1) | EP0879228B1 (pt) |
| JP (1) | JP2000504008A (pt) |
| KR (1) | KR100453707B1 (pt) |
| AT (1) | ATE226940T1 (pt) |
| AU (1) | AU715183B2 (pt) |
| CA (1) | CA2243534C (pt) |
| CZ (1) | CZ292609B6 (pt) |
| DE (1) | DE69716713T2 (pt) |
| DK (1) | DK0879228T3 (pt) |
| ES (1) | ES2187753T3 (pt) |
| HU (1) | HUP9901658A3 (pt) |
| MX (1) | MX209701B (pt) |
| PT (1) | PT879228E (pt) |
| SK (1) | SK283553B6 (pt) |
| WO (1) | WO1997028124A1 (pt) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6486177B2 (en) | 1995-12-04 | 2002-11-26 | Celgene Corporation | Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
| US5837284A (en) | 1995-12-04 | 1998-11-17 | Mehta; Atul M. | Delivery of multiple doses of medications |
| US5922736A (en) * | 1995-12-04 | 1999-07-13 | Celegene Corporation | Chronic, bolus administration of D-threo methylphenidate |
| GB9700912D0 (en) * | 1997-01-17 | 1997-03-05 | Chiroscience Ltd | Resolution |
| US6962997B1 (en) | 1997-05-22 | 2005-11-08 | Celgene Corporation | Process and intermediates for resolving piperidyl acetamide steroisomers |
| US6100401A (en) * | 1998-04-20 | 2000-08-08 | Novartris Ag | Process for preparing the d-threo isomer of methylphenidate hydrochloride |
| US6025502A (en) * | 1999-03-19 | 2000-02-15 | The Trustees Of The University Of Pennsylvania | Enantopselective synthesis of methyl phenidate |
| US20050239830A1 (en) * | 2004-04-26 | 2005-10-27 | Vikram Khetani | Methods of diminishing co-abuse potential |
| CN101076248A (zh) * | 2004-12-09 | 2007-11-21 | 塞尔基因公司 | 使用d－苏型哌甲酯的治疗 |
| US7897777B2 (en) * | 2007-01-05 | 2011-03-01 | Archimica, Inc. | Process of enantiomeric resolution of D,L-(±)-threo-methylphenidate |
| WO2012031125A2 (en) | 2010-09-01 | 2012-03-08 | The General Hospital Corporation | Reversal of general anesthesia by administration of methylphenidate, amphetamine, modafinil, amantadine, and/or caffeine |
| WO2012129551A1 (en) | 2011-03-23 | 2012-09-27 | Ironshore Pharmaceuticals & Development, Inc. | Methods and compositions for treatment of attention deficit disorder |
| US9498447B2 (en) | 2011-03-23 | 2016-11-22 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| US8927010B2 (en) | 2011-03-23 | 2015-01-06 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| US9283214B2 (en) | 2011-03-23 | 2016-03-15 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| US9119809B2 (en) | 2011-03-23 | 2015-09-01 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| US10905652B2 (en) | 2011-03-23 | 2021-02-02 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| US11241391B2 (en) | 2011-03-23 | 2022-02-08 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| US10292937B2 (en) | 2011-03-23 | 2019-05-21 | Ironshore Pharmaceuticals & Development, Inc. | Methods of treatment of attention deficit hyperactivity disorder |
| US9603809B2 (en) | 2011-03-23 | 2017-03-28 | Ironshore Pharmaceuticals & Development, Inc. | Methods of treatment of attention deficit hyperactivity disorder |
| US8916588B2 (en) | 2011-03-23 | 2014-12-23 | Ironshore Pharmaceuticals & Development, Inc. | Methods for treatment of attention deficit hyperactivity disorder |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2957880A (en) * | 1953-12-23 | 1960-10-25 | Ciba Pharm Prod Inc | Process for the conversion of stereoisomers |
| SU466229A1 (ru) * | 1973-01-23 | 1975-04-05 | Всесоюзный научно-исследовательский химико-фармацевтический институт им. С.Орджоникидзе | Способ получени гидрохлорида метилового эфира трео- -фенил- (пиперидил-2)-уксусной кислоты |
| US4254261A (en) * | 1979-10-15 | 1981-03-03 | Merck & Co., Inc. | Dehydroabietylammonium salts of 6-oxo-2-piperidinecarboxylic acid |
| US5733756A (en) * | 1996-01-05 | 1998-03-31 | Celgene Corporation | Lactams and processes for stereoselective enrichment of lactams, amides, and esters |
| US6242464B1 (en) * | 1996-01-22 | 2001-06-05 | Chiroscience Limited | Single isomer methylphenidate and resolution process |
| MX9805870A (pt) * | 1996-01-22 | 1999-01-31 | ||
| GB9604943D0 (en) * | 1996-03-08 | 1996-05-08 | Chiroscience Ltd | Resolution |
-
1997
- 1997-01-31 JP JP9527425A patent/JP2000504008A/ja not_active Ceased
- 1997-01-31 CA CA002243534A patent/CA2243534C/en not_active Expired - Fee Related
- 1997-01-31 DK DK97902435T patent/DK0879228T3/da active
- 1997-01-31 EP EP97902435A patent/EP0879228B1/en not_active Expired - Lifetime
- 1997-01-31 WO PCT/GB1997/000281 patent/WO1997028124A1/en active IP Right Grant
- 1997-01-31 AT AT97902435T patent/ATE226940T1/de not_active IP Right Cessation
- 1997-01-31 PT PT97902435T patent/PT879228E/pt unknown
- 1997-01-31 DE DE69716713T patent/DE69716713T2/de not_active Expired - Fee Related
- 1997-01-31 AU AU16082/97A patent/AU715183B2/en not_active Ceased
- 1997-01-31 KR KR19980705911A patent/KR100453707B1/ko not_active IP Right Cessation
- 1997-01-31 SK SK979-98A patent/SK283553B6/sk unknown
- 1997-01-31 HU HU9901658A patent/HUP9901658A3/hu unknown
- 1997-01-31 ES ES97902435T patent/ES2187753T3/es not_active Expired - Lifetime
- 1997-01-31 CZ CZ19982275A patent/CZ292609B6/cs not_active IP Right Cessation
-
1998
- 1998-07-31 MX MX9806209A patent/MX209701B/es not_active IP Right Cessation
-
2001
- 2001-08-10 US US09/928,139 patent/US7164025B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU715183B2 (en) | 2000-01-20 |
| CA2243534A1 (en) | 1997-08-07 |
| DK0879228T3 (da) | 2003-03-03 |
| JP2000504008A (ja) | 2000-04-04 |
| AU1608297A (en) | 1997-08-22 |
| DE69716713T2 (de) | 2003-07-03 |
| EP0879228A1 (en) | 1998-11-25 |
| HUP9901658A3 (en) | 1999-12-28 |
| CA2243534C (en) | 2003-08-26 |
| SK283553B6 (sk) | 2003-09-11 |
| MX9806209A (es) | 1998-10-31 |
| US20020032335A1 (en) | 2002-03-14 |
| CZ292609B6 (cs) | 2003-11-12 |
| MX209701B (es) | 2002-08-15 |
| EP0879228B1 (en) | 2002-10-30 |
| SK97998A3 (en) | 1999-01-11 |
| CZ227598A3 (cs) | 1998-12-16 |
| WO1997028124A1 (en) | 1997-08-07 |
| ATE226940T1 (de) | 2002-11-15 |
| ES2187753T3 (es) | 2003-06-16 |
| HUP9901658A2 (hu) | 1999-09-28 |
| KR100453707B1 (ko) | 2005-01-25 |
| DE69716713D1 (de) | 2002-12-05 |
| US7164025B2 (en) | 2007-01-16 |
| KR19990082186A (ko) | 1999-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT879228E (pt) | Processo para a preparacao de d-treo-(r,r)-metilfenidato e reciclagem de enantiomeros indesejaveis por epimerizacao | |
| DE69636147D1 (de) | Verfahren zur herstellung von phosphorothioat-oligomeren | |
| ES2155844T3 (es) | Preparacion de n-alquilcarboxilatos de piperidinilo 3,4,4-trisustituidos e intermedios, utiles como antagonistas de opiaceos. | |
| ATE195973T1 (de) | Enzymatische verfahren zur resolution von enantiomeren-mischungen nützlich wie zwischenprodukte zur herstellung von taxanen | |
| PT88177A (pt) | Processo para a preparacao de eteres contendo por exemplo, grupos azabiciclicos | |
| DE69621491T2 (de) | Verfahren zur Herstellung von Epsilon-Caprolactam | |
| ITMI950056A0 (it) | Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide | |
| DE59609854D1 (de) | Verfahren zur herstellung von verkappten polyarylenethern | |
| BR9807936A (pt) | Preparação farmacêutica imuno-tolerante de complexo de pró-trombina, processo para a produção de uma preparação, e, utilização de uma preparação | |
| DE69611484D1 (de) | Verfahren zur Herstellung von Phenol | |
| DE59007171D1 (de) | Verfahren zur herstellung von sclareolid. | |
| DE69020172D1 (de) | Verfahren zur Herstellung von epsilon-Caprolactam. | |
| BR9606981A (pt) | Processo para preparação de intermediários inibidores de protease retroviral | |
| IT8922075A0 (it) | Processo per l'inversione stereochimica di (2s,3s)-2-ammino-3-fenil-1 ,3-propandioli nei corrispondenti enantiomeri (2r,3r) | |
| BR9711003A (pt) | Processo para a prepara-Æo de um dicarboxilato oxadiazina | |
| DE69300551T2 (de) | Verfahren zur Herstellung von (3R,4R)-3-Hydroxy-4-Hydroxymethyl-4-Butanolid. | |
| BR9603115A (pt) | Processo para a separação de trioxano de uma mistura aquosa | |
| DE69007965T2 (de) | Apparatur zur herstellung von alpha-beta-ungesättigten nitrilen. | |
| DE69800901T2 (de) | Verfahren zur Herstellung von Trans 1,4-Cyclohexan-bis-(methylamin) | |
| ATE107935T1 (de) | Verfahren zur herstellung von propylen-ethylen- copolymerisaten. | |
| DE3669154D1 (de) | Verfahren zur herstellung von 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxy-piperidin. | |
| PT1001929E (pt) | Processo para o fabrico de acidos 3-ciano-2,4-di-halogeno-5-fluorobenzoicos | |
| DE69402450T2 (de) | Verfahren zur Herstellung von Urethanen | |
| DE69417061T2 (de) | Verfahren zur herstellung von 2-chlor-1, 3-butadien pfropfcopolymeren | |
| DE69802329D1 (de) | Verfahren zur Herstellung von 3,4 disubstituirten Dinitroanilinen |